CHEBI:180654

{
    "@context": "/terms/",
    "@id": "/treatments/514e252b-fc36-437b-94cd-89421e5f2e0b/",
    "@type": [
        "Treatment",
        "Item"
    ],
    "aliases": [
        "pankbase-consortium:treatment_SARS-CoV-2"
    ],
    "amount": 1,
    "amount_units": "mM",
    "audit": {},
    "award": {
        "@id": "/awards/U24DK138512/",
        "component": "data coordination"
    },
    "biosamples_treated": [],
    "creation_timestamp": "2025-05-06T22:17:43.880578+00:00",
    "depletion": false,
    "description": "A nucleoside analogue with broad-spectrum antiviral activity against influenza, SARS-CoV, SARS-CoV-2, and MERS-CoV.",
    "lab": {
        "@id": "/labs/pankbase-consortium/",
        "title": "Pankbase Consortium, PanKbase"
    },
    "notes": "Unit: MOI",
    "purpose": "stimulation",
    "release_timestamp": "2025-06-15T06:27:10.444885+00:00",
    "schema_version": "7",
    "status": "released",
    "submitted_by": {
        "@id": "/users/5e3038c4-baa5-4589-b3d8-ad2fe634e826/",
        "title": "Ying Sun"
    },
    "submitter_comment": "https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:180654",
    "summary": "Treatment of 1 mM N4-Hydroxycytidine",
    "treatment_term_id": "CHEBI:180654",
    "treatment_term_name": "N4-Hydroxycytidine",
    "treatment_type": "chemical",
    "uuid": "514e252b-fc36-437b-94cd-89421e5f2e0b"
}